Conti F - Search Results

1

Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium".

Perniola S, Chimenti MS, Spinelli FR, Frediani B, Foti R, Ferrigno S, Garufi C, Cassone G, Venerito V, Atzeni F, Caporali R, Conti F, Favalli EG, Iannone F, Sebastiani M, Ferraccioli GF, Lapadula G, Gremese E. Perniola S, et al. Among authors: conti f. J Clin Med. 2023 Apr 9;12(8):2781. doi: 10.3390/jcm12082781. J Clin Med. 2023. PMID: 37109118 Free PMC article. Review.

2

Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A.

Conti F, Priori R, Alessandri C, Spinelli FR, Medda E, Valesini G. Conti F, et al. Lupus. 2000;9(9):676-80. doi: 10.1191/096120300676096627. Lupus. 2000. PMID: 11199922

3

Selective cyclooxygenase-2 inhibition: biological and clinical effects.

Conti F, Spinelli FR, Ossandon A, Valesini G. Conti F, et al. Isr Med Assoc J. 2000 Nov;2(11):841-7. Isr Med Assoc J. 2000. PMID: 11344755 Free article. Review. No abstract available.

4

Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13.

Pittoni V, Bombardieri M, Spinelli FR, Scrivo R, Alessandri C, Conti F, Spadaro A, Valesini G. Pittoni V, et al. Among authors: conti f. Ann Rheum Dis. 2002 Aug;61(8):723-5. doi: 10.1136/ard.61.8.723. Ann Rheum Dis. 2002. PMID: 12117680 Free PMC article.

5

Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies.

Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, Valesini G. Conti F, et al. Arthritis Res Ther. 2004;6(4):R366-72. doi: 10.1186/ar1198. Epub 2004 Jun 17. Arthritis Res Ther. 2004. PMID: 15225372 Free PMC article.

6

Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab.

Conti F, Priori R, Chimenti MS, Coari G, Annovazzi A, Valesini G, Signore A. Conti F, et al. Arthritis Rheum. 2005 Apr;52(4):1224-6. doi: 10.1002/art.20979. Arthritis Rheum. 2005. PMID: 15818709 Free article.

7

Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period.

Conti F, Ceccarelli F, Marocchi E, Magrini L, Spinelli FR, Spadaro A, Scrivo R, Valesini G. Conti F, et al. Ann Rheum Dis. 2007 Oct;66(10):1393-7. doi: 10.1136/ard.2007.073569. Epub 2007 Jul 5. Ann Rheum Dis. 2007. PMID: 17613555 Free PMC article.

8

Infections and treatment of patients with rheumatic diseases.

Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C, Sulli A, Valesini G, Sarzi-Puttini P. Atzeni F, et al. Among authors: conti f. Clin Exp Rheumatol. 2008 Jan-Feb;26(1 Suppl 48):S67-73. Clin Exp Rheumatol. 2008. PMID: 18570757 Review.

9

Switching between TNFalpha antagonists in rheumatoid arthritis: personal experience and review of the literature.

Scrivo R, Conti F, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F, Valesini G. Scrivo R, et al. Among authors: conti f. Reumatismo. 2009 Apr-Jun;61(2):107-17. doi: 10.4081/reumatismo.2009.107. Reumatismo. 2009. PMID: 19633797 Free article. Review.

10

Toll-like receptors and lupus nephritis.

Conti F, Spinelli FR, Alessandri C, Valesini G. Conti F, et al. Clin Rev Allergy Immunol. 2011 Jun;40(3):192-8. doi: 10.1007/s12016-010-8208-0. Clin Rev Allergy Immunol. 2011. PMID: 20596796 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,474 results

Search Page